1
Registered trials
0
Recruiting
1
Unique sponsors
1
Unique IMPs
1
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
Mechanism of action (INN-stem analysis)
IMiD
1 substance
Phase II:
1
Phase II
1 trial-
EndedCelgene Corp. CommercialGOLCADOMIDE
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Celgene Corp. | Commercial | 1 | Phase II | 0 |
New trials by year
2024
1